12:00 AM
Dec 11, 2000
 |  BC Week In Review  |  Company News  |  Management Tracks

Genelabs scientific advisory board update

Genelabs Technologies Inc. (GNLB), Redwood City, Calif.
Business: Autoimmune/Inflammation, Drug discovery
Appointed: Charles Cantor, CSO at Sequenom...

Read the full 72 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >